Status:
UNKNOWN
Study of Osteogenesis Imperfecta Tendon
Lead Sponsor:
Université Catholique de Louvain
Collaborating Sponsors:
Hopital Lariboisière
University Hospital, Lille
Conditions:
Osteogenesis Imperfecta
Eligibility:
All Genders
Brief Summary
Osteogenesis imperfecta (OI) is a rare genetic disease due to a mutation in one of the genes encoding either type I collagen or a protein involved in its synthesis. This leads to bone fragility with f...
Detailed Description
This project aims to study the damage of tendon and ligament in a cohort of patients suffering from osteogenesis imperfecta. The data collected will be put into perspective with those of our first exp...
Eligibility Criteria
Inclusion
- to have an osteogenesis imperfecta
Exclusion
- none, since we want to study different types of osteogenesis imperfecta and consider the effect of age.
Key Trial Info
Start Date :
September 13 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2025
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT06065111
Start Date
September 13 2023
End Date
June 1 2025
Last Update
October 3 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pole de Morphologie
Woluwe-Saint-Lambert, Brussels Capital, Belgium, 1200